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The type VII protein secretion system (T7SS) is conserved across
Staphylococcus aureus strains and plays important roles in virulence
and interbacterial competition. To date, only one T7SS substrate pro-
tein, encoded in a subset of S. aureus genomes, has been function-
ally characterized. Here, using an unbiased proteomic approach, we
identify TspA as a further T7SS substrate. TspA is encoded distantly
from the T7SS gene cluster and is found across all S. aureus strains as
well as in Listeria and Enterococci. Heterologous expression of TspA
from S. aureus strain RN6390 indicates its C-terminal domain is toxic
when targeted to the Escherichia coli periplasm and that it depolar-
izes the cytoplasmic membrane. The membrane-depolarizing activity
is alleviated by coproduction of the membrane-bound TsaI immunity
protein, which is encoded adjacent to tspA on the S. aureus chromo-
some. Using a zebrafish hindbrain ventricle infection model, we
demonstrate that the T7SS of strain RN6390 promotes bacterial rep-
lication in vivo, and deletion of tspA leads to increased bacterial
clearance. The toxin domain of TspA is highly polymorphic and S.
aureus strains encode multiple tsaI homologs at the tspA locus, sug-
gestive of additional roles in intraspecies competition. In agree-
ment, we demonstrate TspA-dependent growth inhibition of
RN6390 by strain COL in the zebrafish infection model that is alle-
viated by the presence of TsaI homologs.
type VII secretion system | Staphylococcus aureus | zebrafish | membrane-
depolarizing toxin | bacterial competition
The type VII secretion system (T7SS) has been characterized inbacteria of the actinobacteria and firmicutes phyla. In patho-
genic mycobacteria, the ESX-1 T7SS secretes numerous proteins
that are essential for virulence and immune evasion (1). The Ess
T7SS of Staphylococcus aureus is also required for pathogenesis in
murine models of infection (2–4), and a longitudinal study of per-
sistent S. aureus infection in the airways of a cystic fibrosis patient
showed that the ess T7SS genes were highly up-regulated during a
13-y timespan (5). It is becoming increasingly apparent, however,
that in addition to having antieukaryotic activity, the T7SS of fir-
micutes mediates interbacterial competition (6–8). Some strains of
S. aureus secrete a DNA endonuclease toxin, EsaD (6, 9), that when
overproduced leads to growth inhibition of a sensitive S. aureus
strain (6). Moreover, Streptococcus intermedius exports at least three
LXG domain-containing toxins—TelA, TelB, and TelC—that me-
diate contact-dependent growth inhibition against a range of gram-
positive species (7).
A large integral membrane ATPase of the FtsK/SpoIIIE family,
termed EssC in firmicutes, is a conserved component of all T7SSs
and probably energizes protein secretion as well as forming part of
the translocation channel (10–15). EsxA, a small secreted protein
of the WXG100 family, is a further conserved T7 component that is
dependent on the T7SS for its translocation across the membrane
(2, 16). In firmicutes, three additional membrane proteins—EsaA,
EssA, and EssB—function alongside the EssC ATPase to mediate
T7 protein secretion (17, 18). In S. aureus the T7 structural com-
ponents are encoded at the ess locus. In commonly studied strains
including Newman, RN6390, and USA300, the T7 substrates EsxB,
EsxC, EsxD, and EsaD are encoded immediately downstream of
essC (Fig. 1A) and are coregulated with the genes coding for ma-
chinery components (2, 3, 6, 9, 19, 20). With the exception of EsaD,
the biological activities of these substrates are unknown, although
mutational studies have suggested that EsxB and EsxC contribute to
persistent infection in a murine abscess model (2, 19).
Despite the ess locus forming part of the core S. aureus genome,
these four substrate proteins are not conserved across S. aureus
isolates, being found in only ∼50% of sequenced strains (21).
Furthermore, inactivation of the T7SS in S. aureus strain ST398
shows a similar decrease in kidney abscess formation as that seen
for T7 mutants in Newman and USA300 (2, 4, 22), despite the fact
that recognizable homologs of EsxB, EsxC, EsxD, and EsaD are
not encoded by this strain (21). This strongly suggests that there
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are further S. aureus T7 substrates that are yet to be identified.
Here we have taken an unbiased approach to identify T7 sub-
strates using quantitative proteomic analysis of culture super-
natants from S. aureus RN6390 wild-type and essC strains. We
identify a substrate, TspA, that is encoded distantly from the ess
gene cluster and is found in all sequenced S. aureus strains. Fur-
ther analysis indicates that TspA has a toxic C-terminal domain
that depolarizes membranes. Using a zebrafish hindbrain ventricle
infection model, we reveal that the T7SS and TspA contribute to
both bacterial replication and interbacterial competition in vivo.
Results
The S. aureus RN6390 T7SS Secreted Proteome. To identify candidate
T7 substrates, RN6390 and an isogenic essC deletion strain (3) were
cultured in the minimal medium RPMI. Both strains grew identically
(Fig. 1B) and expressed components of the T7SS, and as expected
secretion of EsxA was abolished in the essC strain (Fig. 1C). Culture
supernatants were isolated when cells reached OD600nm of 1, and
label-free quantitative proteomics was used to assess changes in
protein abundance of four biological replicates of each secretome.
Following identification of 1,170 proteins, 17 proteins showed, with
high confidence (P < 0.05, two fold change), a decrease in
abundance in the secretome of the essC strain relative to the
RN6390 parent strain (Fig. 1D, Table 1, and Dataset S1).
Proteomic analysis indicated that the secreted core compo-
nent, EsxA, was significantly reduced in abundance in the essC
secretome, as expected from the Western blot analysis (Fig. 1C).
Peptides from the membrane-bound T7 component EsaA, which
has a large surface-exposed loop (23), were also less abundant in
the supernatant of the essC strain, as were EsxD and EsaD,
known substrates of the T7SS (6, 9, 20) (Table 1 and Dataset S1).
The EsxC substrate (19) was also exclusively detected in the
supernatant of the wild-type strain, but only two EsxC peptides
were detected and it did not meet the P < 0.01 cutoff (Dataset
S1). EsxB, another previously identified substrate (2, 24), and
EsaE, which is cosecreted with EsaD (6), were not detected in
any of our analysis.
After EsxD, the protein with the highest relative abundance
in the secretome of the wild-type strain was the uncharacterized
protein SAOUHSC_00584. This protein harbors a predicted
LXG domain, which is common to some T7SS substrates (7).
Other proteins enriched in the secretome of the wild-type strain
include a predicted superantigen (SAOUHSC_00389), the se-
cretory antigen SsaA, two predicted membrane-bound lipo-
proteins (SAOUHSC_01180 and SAOUHSC_02695), two
A
B C
D
Fig. 1. The S. aureus RN6390 T7 secretome. (A) The ess locus in strain NCTC8325 (parent of RN6390). Genes for core components are shaded green, secreted
substrates yellow, EsaE (which is cosecreted with EsaD) in hatched shading, and the cytoplasmic antitoxin EsaG in white. (B) Growth of RN6390 (WT) and the
isogenic ΔessC strain in RPMI medium. Points show mean ± SEM (n = 3 biological replicates). (C) RN6390 (WT) and the ΔessC strain cultured in RPMI growth
medium to OD600 = 1. Samples were separated into supernatant (sn) and cellular (c) fractions (12% Bis-Tris gels) and immunoblotted with anti-EsxA, anti-EssB,
anti-EssC, or anti-TrxA (cytoplasmic protein) antisera. (D) Volcano plot of the quantitative proteomic secretome analysis. Each spot represents an individual
protein ranked according to its statistical P value (y axis) and relative abundance ratio (log2 fold change). The blue dotted lines represent cutoffs for sig-
nificance (P < 0.05; log2 fold-change > 1).
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uncharacterized proteins (SAOUHSC_00406 and SAOUHSC_
02448), and several predicted cytoplasmic proteins (Table 1). A
small number of proteins were found to be enriched in abun-
dance in the essC secretome (Dataset S1), including the heme
oxygenase IsdI, which is known to be up-regulated when the
T7SS is inactivated (25).
SAOUHSC_00584/TspA Localizes to the Membrane Dependent on EssC.
We next constructed tagged variants of each of SAOUHSC_
00389, SAOUHSC_00406, SAOUHSC_00584, SAOUHSC_
02448, and SsaA to probe their subcellular locations in the wild-
type and ΔessC strains. C-terminally HA-tagged SAOUHSC_
00389, SAOUHSC_02448, and SsaA were secreted into the
culture supernatant in an essC-independent manner (SI Appen-
dix, Fig. S1), indicating that these proteins are not substrates of
the T7SS and their reduced abundance in the essC secretome may
arise for pleiotropic reasons. Overproduction of C-terminally Myc-
tagged SAOUHSC_00406 caused cell lysis, seen by the presence
of TrxA in the supernatant samples (SI Appendix, Fig. S1B). In
contrast, a C-terminally Myc-tagged variant of SAOUHSC_00584
was detected only in the cellular fraction (SI Appendix, Fig. S1C).
To probe the subcellular location of SAOUHSC_00584-Myc, we
generated cell wall, membrane, and cytoplasmic fractions. Fig. 2A
shows that the tagged protein localized to the membrane and that
it appears to be destabilized by the loss of EssC. SAOUHSC_
00584 was subsequently renamed TspA (type seven dependent
protein A).
TspA is predicted to be 469 amino acids long and to have
either one (TMHMM) or two (Predictprotein.org) transmem-
brane domains toward its C-terminal end. To determine whether
it is an integral membrane protein, we treated membranes with
urea, which removes peripherally bound proteins by denatur-
ation. Fig. 2B indicates that a large fraction of TspA-Myc was
displaced from the membrane to the cytoplasmic fraction by the
addition of urea, whereas a bona fide integral membrane pro-
tein, EssB (26–28), was not displaced by this treatment. We
conclude that TspA-Myc peripherally interacts with the mem-
brane. This is consistent with findings from the proteomic ex-
periment as peptides along the entire length of TspA were
detected in the secretome (SI Appendix, Fig. S2).
To determine whether TspA-Myc is exposed at the extracel-
lular side, we prepared spheroplasts and treated them with
proteinase K. Fig. 2C shows that at low concentrations of pro-
teinase K, TspA-Myc was proteolytically cleaved to release a
smaller fragment that also cross-reacted with the anti-Myc an-
tibody. At least part of this smaller fragment must be extracel-
lular as it was also degraded as the protease concentration was
increased. An ∼37-kDa C-terminal fragment of TspA-Myc de-
tected natively in the absence of added protease was also ex-
tracellular as it was sensitive to digestion by proteinase K. The
presence of full-length TspA in the culture supernatant in the
proteomic analysis is likely due to surface shedding, a phenom-
enon that has also been seen for the cell wall-anchored protein A
(29). The likely topology of TspA is shown in Fig. 2E.
All S. aureus T7SS substrate proteins identified to date are
found only in a subset of strains, and are linked with specific essC
subtypes. However, TspA is encoded by all S. aureus genomes
examined in Warne et al. (21), and is distant from the ess locus.
This raised the possibility that TspA may be a further secreted
core component of the T7 machinery. To examine this, we
constructed an in-frame tspA deletion in RN6390 and investi-
gated the subcellular location of the T7-secreted component
EsxA and the substrate protein EsxC. Fig. 2D shows that both
EsxA and EsxC are secreted in the absence of TspA. We con-
clude that TspA is a peripheral membrane protein substrate of
the T7SS, whose localization and stability at the extracellular
side of the membrane is dependent on EssC, and that it is not a
core component of the T7SS.
TspA has a Toxic C-Terminal Domain with Membrane Depolarizing
Activity That Is Neutralized by TsaI. Sequence analysis of TspA in-
dicates that homologs are found across the Staphylococci (in-
cluding Staphylococcus argenteus, Staphylococcus epidermidis, and
Staphylococcus lugdunensis), in Listeria species and Enterococci,
but does not provide clues about potential function. However,
analysis of TspA using modeling programs predicts strong struc-
tural similarity to colicin Ia (Fig. 3A), a bacteriocidal protein
produced by some strains of Escherichia coli. Colicin Ia has an
amphipathic domain at its C terminus that inserts into the cyto-
plasmic membrane from the extracellular side to form a voltage-
gated channel (30–32). Some limited structural similarity was also
Table 1. Proteins present in the secretome of RN6390 at an abundance of greater than twofold higher than the secretome of the
isogenic ΔessC strain
Identifier Protein name/description
Relative
abundance WT/ΔessC P value
Unique
peptides
Sequence
coverage, %
SAOUHSC_00267 EsxD (T7 secreted substrate) 113.6* 8.00 × 10−6 4 47.6
SAOUHSC_00584 (TspA) Uncharacterized LXG domain protein 15.9 2.45 × 10−3 16 44.3
SAOUHSC_00268 EsaD (T7 secreted nuclease) 15.8 1.64 × 10−3 24 44.5
SAOUHSC_00389 Uncharacterized. Predicted superantigen-like protein 6.7* 0.00109 2 25.6
SAOUHSC_00257 EsxA (Secreted T7 core component) 4.6 0.00425 6 81.4
SAOUHSC_00406 Uncharacterized protein 3.0 0.00272 10 31.7
SAOUHSC_01342 Nuclease SbcCD subunit C 2.9 0.00291 7 9.7
SAOUHSC_01949 Intracellular serine protease, putative 2.6 0.00421 7 20.8
SAOUHSC_02028 PhiETA ORF57-like protein 2.4 5.21 × 10−3 13 26.4
SAOUHSC_01191 50S ribosomal protein L28 2.3 0.00498 3 24.2
SAOUHSC_02695 Uncharacterized protein with DUF4467/cystatin-like domain 2.3 0.00337 5 31
SAOUHSC_01180 Uncharacterized protein 2.3 0.00286 26 73.2
SAOUHSC_00258 EsaA (membrane-bound T7 core component) 2.2 0.00397 71 59.4
SAOUHSC_02448 Uncharacterized protein with alpha/beta hydrolase fold 2.1 0.00353 17 59.2
SAOUHSC_02042 Phi Mu50B-like protein 2.1 0.00141 2 18.9
SAOUHSC_02027 SLT orf 129-like protein 2.1 1.22 × 10−3 4 56
SAOUHSC_02883 Staphylococcal secretory antigen SsaA 2.0 0.00431 5 43.1
A full list of all of the proteins identified in this analysis is given in Dataset S1.
*Not detected in the ΔessC secretome.
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predicted with the type III secretion translocator protein YopB,
which undergoes conformational changes to form pores in host
cell membranes (33).
To investigate the function of TspA, DNA encoding full-length
TspA or the C-terminal domain alone (TspACT) was cloned into a
tightly regulatable vector for expression in E. coli. Fig. 3C shows
that production of TspA or TspACT did not affect E. coli survival.
However, colicin Ia shows a sidedness for channel formation be-
cause it requires a transmembrane voltage for full insertion (34).
We therefore targeted TspACT to the periplasm of E. coli by fusing
to a Tat signal peptide (35, 36). Fig. 3C shows that this construct
was toxic, and that toxicity was relieved when the Tat pathway was
inactivated (Fig. 3C), consistent with the C-terminal domain of
TspA exerting toxic activity from the periplasmic side of the
membrane.
Bacterially produced toxins, particularly those that target other
bacteria, are often coexpressed with immunity proteins that pro-
tect the producing cell from self-intoxication. For example, pro-
tection from colicin Ia toxicity is mediated by the membrane-
bound Iia immunity protein (37). TspA is genetically linked to a
repeat region of 10 genes encoding predicted polytopic membrane
proteins with DUF443 domains (Fig. 3B). Topological analysis of
these proteins predicts the presence of five transmembrane do-
mains with an Nout-Cin configuration. Consistent with this, West-
ern blot analysis confirmed that a C-terminally HA-tagged variant
of SAOUHSC_00585, which is encoded directly adjacent to TspA,
A B
C
E
D
Fig. 2. SAOUHSC_00584/TspA is an extracellular peripheral membrane protein. (A) RN6390 (WT) and the ΔessC strain harboring pRAB11 (empty) or
pRAB11-TspA-Myc were cultured in TSB growth medium. Following induction of plasmid-encoded TspA-Myc production, cells were harvested and frac-
tionated into cell wall (cw), membrane (m), and cytoplasmic (cyt) fractions. Samples were separated (12% Bis-Tris gels) and immunoblotted with anti–Myc-
HRP, anti-TrxA (cytoplasmic protein), anti-Spa (cell wall), or anti-SrtA (membrane) antisera. An asterisk (*) represents nonspecific cross-reacting band cor-
responding to Spa. (B) Cell extracts from the RN6390 samples in A were incubated with 4 M urea, membranes were isolated and the urea-treated cytoplasm
(cyt+) and membranes (m+) were separated alongside the cell wall and untreated cytoplasm and membrane fractions on a 12% Bis-Tris gel and immuno-
blotted with anti-Myc and anti-SrtA antisera. (C) Spheroplasts from strain RN6390 producing TspA-Myc were incubated with the indicated concentrations of
Proteinase K (pk) at 4 °C for 30 min. A sample of spheroplasts from RN6390 containing pRAB11 (empty) is shown as a negative control. Samples were
separated on a 12% Bis-Tris gel and immunoblotted using anti-Myc, anti-SrtA, anti-EssB, and anti-TrxA antisera. (D) S. aureus RN6390 or the isogenic ΔessC or
ΔtspA strains were cultured in TSB medium and harvested at OD600 of 2. Supernatant (sn) and cellular (c) fractions (equivalent of 100 μL culture supernatant
and 10 μL of cells adjusted to OD600 of 2) were separated on Bis-Tris gels (15% acrylamide) and immunoblotted using anti-EsxA, EsxC, or TrxA antisera. (E)
Model for organization of TspA in the S. aureus envelope. CTD, C-terminal (channel-forming) domain.
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localized to the membrane of S. aureus (Fig. 3D). To determine
whether SAOUHSC_00585 offers protection against the toxicity
of the TspA C-terminal domain, we coproduced the AmiAss–
TspACT fusion alongside SAOUHSC_00585 in E. coli. Fig. 3C
shows that coproduction of SAOUHSC_00585 offered protection
of E. coli, particularly when it was constitutively expressed from
the pSUPROM plasmid. SAOUHSC_00585 was subsequently
renamed TsaI (TspA immunity protein) (Fig. 3E).
Pore-forming proteins are widely used as toxins to target ei-
ther prokaryotic or eukaryotic cells (38, 39). To assess whether
TspA has pore/channel-forming activity we investigated whether
the production of AmiAss–TspACT in E. coli dissipated the
membrane potential. Initially we used the BacLight assay, which
is based on the dye 3,3′-diethyloxacarbocyanine iodide DiOC2(3)
that exhibits green florescence in dilute solution but a red shift
following membrane potential-driven accumulation in the bac-
terial cytosol. After sorting of E. coli by flow cytometry, the
majority of cells harboring the empty vector exhibited red fluo-
rescence, which shifted to green following treatment with the
uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP).
A similar shift in fluorescence was also observed when E. coli
produced the AmiAss–TspACT fusion (Fig. 4A), indicative of loss
of membrane potential. Coproduction of TsaI offered some pro-
tection from AmiAss–TspACT-induced depolarization (Fig. 4A).
We conclude that the C-terminal domain of TspA has membrane
depolarizing activity.
Membrane depolarization may arise from the formation of
ion-selective channels or larger, nonselective pores. To further
A B
C
D E
Fig. 3. Directed export of TspA C-terminal domain to the periplasm of E. coli is toxic. (A) Structural model for residues 9 to 416 of TspA generated using
RaptorX (raptorx.uchicago.edu/), modeled on the colicin Ia structure (30). The predicted channel-forming region is shown in yellow. (B) The tspA locus. Genes
coding for DUF443 proteins are shown in yellow. (C) E. coli strain MG1655 harboring empty pBAD18-Cm or pBAD18-Cm encoding either full-length TspA, the
TspA C-terminal domain (TspACT), TspACT with the AmiA signal sequence at its N terminus (AmiAss–TspACT), AmiAss–TspACT and TsaI (SAOUHSC_00585),
AmiAss–TspACT/TsaI alongside an additional plasmid-encoded copy of TsaI (from pSU-TsaI), or strain SG3000 (as MG1655, ΔtatABCD) harboring pBAD18-
AmiAss–TspACT was serially diluted and spotted on LB plates containing either D-glucose or L-arabinose, as indicated. Plates were incubated at 37 °C for 16 h,
after which they were photographed. (D) S. aureus cells harboring pRAB11 (empty) and pRAB11-SAOUHSC_00585-HA were cultured in TSB medium and
expression of SAOUHSC_00585-HA induced by addition of 500 ng/mL ATc when the cells reached OD600 of 0.4. The cells were then harvested at OD600 of 2.
The cells were spun down and subsequently fractionated into cell wall (cw), membrane (m), and cytoplasmic (cyt) fractions. The fractionated samples were
separated on Bis-Tris gels and immunoblotted using the anti-HA antibody, or control antisera raised to TrxA (cytoplasmic protein), protein A (Spa, cell wall), or
sortase A (SrtA, membrane). (E) Schematic representation of the toxicity experiments in C, and the inhibition of TspACT toxicity by the membrane-embedded
immunity protein, TsaI. IM, inner membrane; OM, outer membrane; PP, periplasm.
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investigate the mechanism of membrane depolarization, we used
single-cell microscopy that combines the voltage-sensitive dye
DisC3(5) with the membrane-impermeable nucleic acid stain
Sytox green (40). E. coli cells incubated with Polymyxin B, which
produces large ion-permeable pores in the E. coli cell envelope
(41), showed strong labeling with Sytox green, indicative of
permeabilization, coupled with very low DisC3(5) fluorescence
(Fig. 4 B–D). In contrast, cells harboring the empty vector had
high DisC3(5) fluorescence that was unaffected by supplemen-
tation with the inducer L-arabinose, and did not stain with Sytox
green. Cells expressing the AmiAss–TspACT fusion following
incubation with arabinose rapidly depolarized, as evidenced by
the marked reduction in DisC3(5) fluorescence, but did not
detectably stain with Sytox green, even after prolonged periods
of incubation (Fig. 4 B–D and SI Appendix, Fig. S3). Therefore, it
appears that TspA acts by triggering membrane depolarization
but does so by forming ion channels rather than larger, nonse-
lective pores in the E. coli inner membrane. Again, coproduction
of TsaI significantly protected cells from AmiAss–TspACT-in-
duced depolarization, confirming that it acts as an immunity
protein (Fig. 4 B–D).
Bacterial channel-forming toxins have been reported that have
either bacteriocidal (42) or bacteriostatic (43) activity. To de-
termine whether the C-terminal domain of TspA was bacter-
iocidal or bacteriostatic, the growth of E. coli producing
AmiAss–TspACT was monitored. It was observed that upon
production of AmiAss–TspACT, E. coli ceased to grow (Fig. 4E);
however, quantification of the colony forming units (cfu) indi-
cated that the cells did not lose viability (Fig. 4F), pointing to a
bacteriostatic action of TspA. We conclude that the C-terminal
domain of TspA is a channel-forming toxin with bacteriostatic
activity that is neutralized by the action of TsaI.
A Zebrafish Model for S. aureus Infection and T7SS Activity.We next
probed whether TspA was important for S. aureus virulence,
initially through the development of an immunocompetent mu-
rine model of S. aureus pneumonia, which failed to reveal the
impact of T7SS activity in vivo (SI Appendix, Fig. S4). Given that
there are likely to be roles for the T7SS in bacterial competition
as well as direct interaction with the host, we next developed a
model where these two potentially confounding factors could be
investigated. The zebrafish (Danio rerio), a widely used verte-
brate model for development, has recently been adapted to study
bacterial infection by human pathogens (44). The hindbrain
ventricle offers a sterile compartment that can be used to follow
bacterial interactions in vivo (45). We first assessed the utility of
this infection model by testing the effect of dose and temperature
on survival for S. aureus inoculated into the hindbrain ventricle of
zebrafish larvae 3 d postfertilization (dpf) (SI Appendix, Fig. S5A).
Clear dose-dependent zebrafish mortality was observed, with
∼90% of zebrafish surviving a low dose of S. aureus infection (7 ×
103 cfu), whereas only ∼55% survived a higher dose (2 × 104 cfu)
(SI Appendix, Fig. S5B). Although 28.5 °C is the optimum tem-
perature for zebrafish larvae development, S. aureus has a tem-
perature optimum of 30 to 37 °C for growth. In agreement with
this, we observed significantly increased zebrafish mortality at
33 °C (relative to 28.5 °C) at high-dose infection (SI Appendix,
Fig. S5B).
We next assessed whether there was a role for the T7SS in
zebrafish mortality. For these experiments, larvae at 3 dpf were
inoculated in the hindbrain ventricle with 2 × 104 cfu of RN6390
or an isogenic strain, RN6390 Δess, lacking all 12 genes (esxA
through esaG) at the ess locus (3), and incubated at 33 °C. We
routinely observed that zebrafish mortality was significantly re-
duced, at both 24 and 48 h postinoculation (hpi), for zebrafish
infected with the RN6390 Δess strain compared to the wild-type
(Fig. 5 A and C and SI Appendix, Fig. S5C). In agreement, total
bacterial counts of infected zebrafish revealed that following an
initial period of 6 h, where both strains replicated in a similar
manner, there was a significant decrease in recovery of the Δess
strain compared to the wild-type after 9 h (Fig. 5 B and D and SI
Appendix, Fig. S5D), suggesting that bacteria lacking the T7SS
are more rapidly cleared in vivo. We also tested a second S. au-
reus strain, COL, in this assay. COL was only weakly virulent at 24
hpi, but at high dose substantial mortality was seen after 48 h (SI
Appendix, Fig. S6A). As before, zebrafish mortality was at least in
part dependent on a functional T7SS (SI Appendix, Fig. S6B),
although we observed no difference in bacterial burden between
the wild-type and ΔessC strain at the timepoints sampled (SI
Appendix, Fig. S6C). We conclude that the T7SS plays a role in
virulence of S. aureus in this zebrafish infection model.
In addition to TspA, a second T7SS-secreted toxin, EsaD [also
called EssD (9, 46)], a nuclease, has been identified in some S.
aureus strains. EsaD was shown to inhibit growth of a competitor
S. aureus strain in vitro (6), but has also been directly implicated
in virulence through modulation of cytokine responses and ab-
scess formation (9, 46). We therefore determined whether TspA
or EsaD was required for virulence in the zebrafish infection
model. Infection of larvae with strain RN6390 lacking TspA
resulted in levels of mortality intermediate between the wild-type
and Δess strain (Fig. 5A), and a significantly reduced bacterial
burden relative to the wild-type strain at 9 hpi (Fig. 5B). In
contrast, no difference was observed in either zebrafish mortality
(Fig. 5C) or bacterial burden (Fig. 5D) between infection with
RN6390 and an isogenic esaD mutant, indicating no detectable
role of EsaD in virulence. Taking these data together, we con-
clude that zebrafish infection can be used to investigate the role
of T7SS effectors in vivo, and that TspA (but not EsaD) con-
tributes to T7SS-mediated bacterial replication in vivo.
Previous studies have shown that the T7SS of S. aureus is in-
volved in modulating the murine host immune response (9, 46).
To test whether altered immune responses mediate the increased
clearance of the Δess and ΔtspA deletion strains at 9 hpi, we in-
vestigated the role of the T7SS in the zebrafish larval cytokine
response during S. aureus infection in vivo (SI Appendix, Fig. S7).
The expression of two host proinflammatory markers IL-8 (cxcl8)
and IL-1β (il-1b) were quantified using qRT-PCR in larvae in-
fected with 2 × 104 cfu of RN6390 wild-type, Δess, ΔtspA, and
ΔesaD strains. In comparison to PBS-injected larvae, S. aureus
infection caused a robust increase in both cxcl8 and il-1b expres-
sion at 6 hpi (when the bacterial burden among strains was simi-
lar) (SI Appendix, Fig. S7). However, no significant difference in
gene expression was observed among larvae infected with wild-
type and any of the three deletion strains (Δess, ΔtspA, and
ΔesaD) (SI Appendix, Fig. S7).
Neutrophils represent the first line of defense against S. aureus
infection (47) and the recently discovered substrate of EssC var-
iant 2 strains, named EsxX, has been implicated in neutrophil lysis,
therefore contributing to evasion of the host immune system (48).
In contrast, the T7SS of Mycobacterium tuberculosis (ESX-1) is
associated with manipulation of the inflammatory response
during infection, allowing for bacterial replication in macrophages
(49–52). To investigate whether the S. aureus T7SS modulates in-
teraction with leukocytes, we analyzed the recruitment of immune
cells to the hindbrain using two transgenic lines in which dsRed is
expressed specifically in neutrophils [Tg(lyz::dsRed)] or mCherry
is expressed specifically in macrophages [Tg(mpeg::Gal4-FF)gl25/
Tg(UAS-E1b::nfsB.mCherry)c264, herein Tg(mpeg1::G/U::mCherry)].
Zebrafish larvae were infected with RN6390 wild-type, Δess, and
ΔtspA strains in the hindbrain ventricle at 3 dpf and imaged under a
fluorescent stereomicroscope at 0, 3, and 6 hpi in order to monitor
neutrophil (SI Appendix, Fig. S8 A and B) and macrophage (SI
Appendix, Fig. S8C andD) behavior. In zebrafish larvae infected with
S. aureus, a significant increase in neutrophil recruitment to the
hindbrain ventricle was detected in comparison to PBS-injected
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larvae at both 3 and 6 hpi (SI Appendix, Fig. S8B). However, no
difference in neutrophil recruitment to the Δess and ΔtspA strains
relative to wild-type was detected at any of the time points tested (SI
Appendix, Fig. S8B). Similar to the neutrophil recruitment experi-
ments, a significant increase in macrophage recruitment to the site
of S. aureus infection was observed when compared to PBS-injected
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Fig. 4. The C-terminal domain of TspA has bacteriostatic activity and disrupts the membrane potential. (A) E. coliMG1655 harboring pBAD18-Cm (empty), or pBAD18-
Cm encoding AmiAss–TspACT or AmiAss–TspACT/TsaI were grown in the presence of 0.2% L-arabinose for 1 h at which point they were diluted to 1 × 10
6 cells per mL and
supplemented with 30 μMDiOC2(3) for 30 min. One sample of MG1655 harboring pBAD18 (empty) was also supplemented with 5 μMCCCP at the same time as DiOC2(3)
addition. Strains were analyzed by flow cytometry. (B–D) The same strain and plasmid combinations asAwere grown in the presence (induced) or absence (uninduced) of
0.2% L-arabinose for 30 min, after which they were supplemented with DisC3(5) and Sytox green and (B) imaged by phase-contrast and fluorescence microscopy. (Scale
bar: 3 μm.) (C and D) Fluorescence intensities of (C) DisC3(5) and (D) Sytox green for each sample was quantified using ImageJ. A control sample where Polymyxin B was
added to the uninduced empty vector control for 5 min before supplemented with DisCs(5) and Sytox green was included in each experiment. (E and F) Growth of E. coli
MG1655 harboring pBAD18-Cm (empty), or pBAD18-Cm encoding AmiAss–TspACT or AmiAss–TspACT/TsaI upon induction with 0.2% L-arabinose. LB medium was inoc-
ulated with an overnight culture of E. coli strainMG1655 harboring the indicated constructs to a starting OD600 of 0.1. Cells were incubated at 37 °C and allowed to reach
an OD600 of 0.5 (indicated by time 0) before supplementing the growth medium with 0.2% L-arabinose (inducing conditions). The growth was monitored every 2 h and
the colony forming units at each time point was determined. Points and bars show mean ± SEM (n = 3 biological replicates). (E) Significance testing was performed by
calculating the area under the curve (AUC) for each experimental replicate using GraphPad Prism 7.0 and then performing a one-way ANOVAwith Sidak’s correction. (F)
Significance testing performed using a one-way ANOVAwith Sidak’s correction at each timepoint. *P < 0.05 **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, not significant.
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larvae at 3 hpi (SI Appendix, Fig. S8D). However, there was no
significant difference in macrophage recruitment among the wild-
type and T7SS mutant strains (SI Appendix, Fig. S8D).
T7SS-Dependent Bacterial Competition In Vivo. Although TspA is
required for optimal S. aureus virulence in the zebrafish model,
the observed toxicity when heterologously produced in E. coli
coupled with the presence of immunity genes encoded down-
stream of tspA strongly suggested that secreted TspA may also
have antibacterial activity. Previously, to observe antibacterial
activity of the nuclease EsaD in laboratory growth media re-
quired the toxin to be overproduced from a multicopy plasmid
(6). However, zebrafish larvae have recently been adapted to
study bacterial predator–prey interactions (45), and we reasoned
that since the T7SS was active in our zebrafish infection model it
may also provide a suitable experimental system to investigate
the impact of T7-mediated bacterial competition in vivo.
In these experiments we used COL as the attacker strain and
RN6360 and its derivatives as the target; it should be noted that
these strains produce the same TspA and EsaD isoforms, as well
as similar suites of immunity proteins. COL was coinoculated
into the hindbrain ventricle, at a 1:1 ratio, with either RN6390
or an isogenic strain lacking all potential immunity proteins
for EsaD and TspA (FRU1; RN6390 Δsaouhsc00268-00278,
Δsaouhsc00585-00602). A significant reduction in recovery of the
target strain lacking immunity genes was observed compared to
the isogenic parental strain at 15 h postinfection (Fig. 6A).
Conversely, there was significantly greater zebrafish mortality at
24 h after coinoculation of COL with the wild-type RN6390 than
the immunity mutant strain (Fig. 6B). Since COL is almost
completely avirulent at this time point (SI Appendix, Fig. S6), we
infer that mortality arises from RN6390, and as the wild-type
strain survives better than the immunity deletion strain when
coinoculated with COL, this accounts for the greater zebrafish
mortality.
To confirm that reduced growth of the RN6390 immunity
mutant strain was dependent upon a functional T7SS in the
attacking strain, we repeated the coinoculation experiments us-
ing a T7 mutant strain of COL (COL ΔessC). The RN6390
immunity mutant strain showed significantly higher recovery
after 15 h in the presence of the COL T7 mutant strain than wild-
type COL (Fig. 6C) and accordingly this was linked with reduced
zebrafish survival (Fig. 6D). Collectively, these data highlight the
utility of zebrafish for investigating S. aureus competition in vivo,
and demonstrate that bacterial competition and zebrafish mor-
tality is dependent on a functional T7SS in the attacking strain
(COL). This is outlined in the schematic shown in Fig. 6E.
Conversely, the ability of the prey strain (RN6390) to survive T7-
dependent killing is dependent upon the immunity proteins
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Fig. 5. The T7SS contributes to virulence in a zebrafish infection model. (A) Survival curves of 3 dpf zebrafish lyz:dsRed larvae infected in the hindbrain
ventricle with RN6390-gfp (WT) or otherwise isogenic Δess-gfp or ΔtspA-gfp strains at a dose of ∼2 × 104 cfu and incubated at 33 °C for 48 hpi. Data are
pooled from four independent experiments (n = 25 to 51 larvae per experiment). Results were plotted as a Kaplan–Meier survival curve and the P value
between conditions was determined by log-rank Mantel–Cox test. (B) Enumeration of recovered bacteria at 0, 6, 9, or 24 hpi from zebrafish larvae infected
with the same strains as A. Pooled data from three independent experiments. Circles represent individual larva, and only larvae that survived the infection
were included. No significant differences observed between strains at 0, 6, or 24 hpi. Mean ± SEM also shown (horizontal bars). Significance testing was
performed using a one-way ANOVA with Sidak’s correction at each timepoint. (C) Survival curves of 3 dpf zebrafish lyz:dsRed larvae infected in the hindbrain
ventricle with RN6390-gfp (WT) or otherwise isogenic Δess-gfp, ΔesaD-gfp strains at a dose of ∼2 × 104 cfu and incubated at 33 °C for 48 hpi. Data are pooled
from three independent experiments (n = 26 to 32 larvae per experiment). Results are plotted as a Kaplan–Meier survival curve and the P value between
conditions was determined by log-rank Mantel–Cox test. (D) Enumeration of recovered bacteria at 0, 6, 9, or 24 hpi from zebrafish larvae infected with the
strains as C. Pooled data from three independent experiments. Circles represent individual larva, and only larvae having survived the infection were included.
No significant differences observed between strains at 0, 6, or 24 hpi. Mean ± SEM also shown (horizontal bars). Significance testing was performed using a
one-way ANOVA with Sidak’s correction at each timepoint. **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, not significant.
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against EsaD and TspA, because when these are not present,
fewer bacteria are recovered.
Finally, we investigated which of the EsaD and TspA toxins
was responsible for interstrain competition by using variants of
COL deleted for either tspA or esaD as the attacking strain. It
was seen that in the absence of either TspA (Fig. 7A) or EsaD
(Fig. 7C), there was a significant increase in recovery of the
RN6390 Δsaouhsc00268-00278, Δsaouhsc00585-00602 prey strain,
indicating that each of these toxins has activity against the target
strain. However, there was a more pronounced increase in
zebrafish mortality when the attacker strain lacked esaD than tspA
(compare Fig. 7 B and D), suggesting that EsaD has the more
potent antibacterial activity in these conditions.
Discussion
Here we have taken an unbiased approach to discover substrates
of the T7SS in S. aureus RN6390, identifying the LXG-domain
protein, TspA. TspA localizes to the cell envelope and has a toxic
C-terminal domain that has membrane-depolarizing activity.
While all other previously identified T7 substrates are encoded
at the ess locus and are associated with specific essC subtypes
(21, 48), TspA is encoded elsewhere on the genome, and is
conserved across all S. aureus strains. This suggests TspA plays
a key role in S. aureus, and indeed we show using a zebrafish
infection model that it contributes to T7SS-mediated bacterial
replication in vivo.
Pore- and channel-forming toxins are key virulence factors
produced by many pathogenic bacteria (53) that can act both
extracellularly to form pores in eukaryotic cells, like some bac-
terial hemolysins (54), or intracellularly for example by altering
permeability of the phagosome, like the pore-forming toxin
Listeriolysin-O, or the type III secretion system effector VopQ
(55, 56). The S. aureus T7SS has been strongly linked with
modulating the host innate immune response (9, 46). However,
we did not observe any significant difference between wild-type
and T7SS mutant strains in modulating cytokine expression and
phagocyte recruitment in zebrafish larvae. Although the precise
mechanism by which the T7SS and TspA interacts with host cells
remains to be determined, we hypothesize that the T7SS plays a
role after phagocytosis by immune cells to influence intracellular
A B
C D
E
Fig. 6. Development of an in vivo model to study bacterial competition. Wild-type AB zebrafish larvae at 3 dpf were coinfected with a 1:1 mix of an attacker
strain (either COL-mCherry [WT] or COL ΔessC-mCherry as indicated) and a target strain (either RN6390-gfp (WT) or RN6390 Δ00268-278 Δ00585-00602-gfp, as
indicated). (A and C) Enumeration of recovered attacker and prey bacteria from zebrafish larvae at 0, 15, or 24 hpi. Pooled data from three independent
experiments. Mean ± SEM also shown (horizontal bars). Significance testing performed by unpaired t test. (B and D) Survival curves of zebrafish injected with
the indicated strain pairs. Data are pooled from three independent experiments. Results are plotted as a Kaplan–Meier survival curve and the P value between
conditions was determined by log-rank Mantel–Cox test. *P < 0.05, **P < 0.01, ****P < 0.0001, ns, not significant. (E) Model highlighting the role for the T7SS
in competition in vivo.
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survival. Future work using high-resolution single-cell micros-
copy would allow for individual S. aureus cells, as well as their
interactions with neutrophils and macrophages, to be tracked
in vivo.
Sequence alignments indicate that the C-terminal domain of
TspA is polymorphic across S. aureus strains (SI Appendix, Fig.
S9) and structural modeling of TspA suggests homology to co-
licin Ia. Colicin Ia is a toxin that forms voltage-gated ion chan-
nels in the plasma membrane of sensitive E. coli strains. The
formation of these channels results in lysis of target bacteria (31,
42). Heterologous expression of the C-terminal predicted
channel-forming domain of TspA was shown to dissipate the
membrane potential of E. coli when it was targeted to the peri-
plasm, probably through formation of an ion channel. Unlike
colicin Ia, however, heterologous production of the TspA toxin
domain was associated with a bacteriostatic rather than a bac-
teriocidal activity. Colicins and pyocins are also examples of
polymorphic toxins (39) and the producing cells are generally
protected from colicin-mediated killing by the presence of im-
munity proteins (37). A cluster of membrane proteins from the
DUF443 domain family are encoded downstream of tspA, and
we show that at least one of these (SAOUHSC_00585; TsaI) acts
as an immunity protein to TspA by protecting E. coli from TspA-
induced membrane potential depletion.
Polymorphic toxins are frequently deployed to attack com-
petitor bacteria in polymicrobial communities (38), and there is
growing evidence that a key role of the T7SS in some bacteria is
to mediate inter- and intraspecies competition (6, 7). In addition
to TspA, many commonly studied strains of S. aureus, including
RN6390 and COL, also secrete a nuclease toxin, EsaD (6). We
adapted our zebrafish larval infection model to assess the role of
the T7SS and the secreted toxins TspA and EsaD in intraspecies
competition. We observed that strain COL was able to out-
compete RN6390 in a T7SS-dependent manner in these exper-
iments, provided that RN6390 was lacking immunity proteins to
TspA and EsaD. Experiments with individual COL attacker
strains deleted for either tspA or esaD showed that each of the
toxins contributed to the competitiveness of COL in these assays.
As S. aureus is a natural colonizer of human nares and can also
exist in polymicrobial communities in the lungs of cystic fibrosis
patients, we suggest that secreted T7 toxins including TspA allow
S. aureus to establish its niche by outcompeting other bacteria.
Indeed, the observation that the T7SS gene cluster is highly up-
regulated in the airways of a cystic fibrosis patient (5) would be
consistent with this hypothesis.
LXG domain proteins appear to form a large substrate family
of the firmicutes T7SS. Three LXG domain proteins of S.
intermedius have been shown to mediate contact-dependent in-
hibition (7), and the association of TspA with the S. aureus cell
envelope would also imply that toxicity is contact-dependent.
The LXG domain is predicted to form an extended helical
hairpin, which could potentially span the cell wall, displaying the
toxin domain close to the surface. How any of these toxin do-
mains reach their targets in the prey cell is not clear. One
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Fig. 7. TspA and EsaD dependent bacterial competition in vivo. Wild-type AB zebrafish larvae at 3 dpf were coinfected with a 1:1 mix of an attacker strain
(either COL-mCherry [WT], COL ΔtspA-mCherry or COL ΔesaD-mCherry as indicated) and a target strain (RN6390 Δ00268-278 Δ00585-00602-gfp). (A and C)
Enumeration of recovered attacker and prey bacteria from zebrafish larvae at 0, 15, or 24 hpi. Pooled data from three independent experiments. Mean ± SEM
also shown (horizontal bars). Significance testing performed by unpaired t test. (B and D) Survival curves of zebrafish injected with the indicated strain pairs.
Data are pooled from three independent experiments. Results are plotted as a Kaplan–Meier survival curve and the P value between conditions was de-
termined by log-rank Mantel–Cox test. **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, not significant.
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possibility is that the toxin domain is taken up into the target cell
upon interaction with a surface receptor, as observed for the type
V-dependent contact inhibition systems in gram-negative bac-
teria (57, 58). During this process the CdiA protein, which also
has a C-terminal toxin domain, is proteolyzed, releasing the toxin
to interact with its cellular target (59). Further work would be
required to decipher the mechanisms by which LXG toxins ac-
cess target cells and whether the toxin domains undergo prote-
olysis to facilitate cellular entry.
In conclusion, channel-forming toxin substrates have been
associated with other protein secretion systems (43, 55–57), but
this is unique in being functionally described for the T7SS. To
our knowledge it is only the second bacterial exotoxin identified
to have a phenotype in both bacterial competition and virulence
assays, after VasX from Vibrio cholerae (60, 61).
Materials and Methods
Bacterial Strains, Plasmids, and Growth Conditions. Construction of strains and
plasmids, and growth conditions are described in SI Appendix, SI Materials
and Methods. Plasmids and strains used in this study are given in SI Ap-
pendix, Tables S1 and S2.
Mass Spectrometry Data Analysis and Label-Free Quantitation. Preparation of
S. aureus culture supernatants for proteomic analysis is detailed in SI Ap-
pendix, SI Materials and Methods. Sample preparation and mass spectrom-
etry analysis was performed similar to previously described work (62–65) and
detailed methods are described in SI Appendix, SI Materials and Methods.
Cell Fractionation and Western Blotting. Preparation of S. aureus cell and su-
pernatant samples for Western blotting, and subcellular fractionation of S. au-
reus into the cell wall, membrane, and cytoplasmic fractions were as described
previously (3). Preparation of urea-washed membrane fractions was adapted
from Keller et al. (66). Briefly, broken cell suspensions were thoroughly mixed
with a final concentration of 4 M urea and incubated for 20 min at room
temperature. Membranes were harvested by ultracentrifugation (227,000 × g,
30 min). The supernatant was retained as the urea-treated cytoplasmic fraction
and the membrane pellet resuspended in 1× PBS, 0.5% Triton X-100. For sphe-
roplast preparation, the method of Götz et al. (67) was adapted. Briefly, strains
were cultured as described above, cells were harvested at OD600 of 2.0, and
resuspended in Buffer A (0.7 M sucrose, 20 mM maleate, 20 mMMgCl2, pH 6.5).
Lysostaphin and lysozyme were added at 20 μg/mL and 2 mg/mL final concen-
tration, respectively, and cells incubated at 37 °C for 1 h. Cell debris was pelleted
by centrifugation (2,500 × g for 8 min) and the resulting supernatant centrifuged
at 16,000 × g for 10 min to pellet the spheroplasts. Spheroplasts were resus-
pended in Buffer A and treated with increasing concentrations of Proteinase K
on ice for 30 min. Next, 0.5 mM phenylmethylsulfonyl fluoride was added to
terminate the reaction and samples mixed with 4× Nu PAGE LDS sample buffer
and boiled for 10 min prior to further analysis. Western blotting was performed
according to standard protocols using the following antibody dilutions α-EsxA (3)
1:2,500; α-EsxC (3) 1:2,000; α-EssB (3) 1:10,000; α-TrxA (68) 1:25000; α-SrtA
(Abcam, catalog number ab13959) 1:3,000; α-HA (HRP-conjugate, Sigma cata-
log number H6533) α-Myc (HRP-conjugate, Invitrogen catalog number R951-25)
1:5,000; and goat anti Rabbit IgG HRP conjugate (Bio-Rad, catalog number 170-
6515) 1:10,000.
Bacterial Membrane Potential Detection. To assess bacterial membrane po-
tential, the method of Miyata et al. (69) was adapted, using the BacLight
bacterial membrane potential kit (Invitrogen). Detailed methods to assess
both bacterial membrane potential and permeabilization are described in SI
Appendix, SI Materials and Methods.
Zebrafish Infection.Wild-type (AB strain) or transgenic Tg(lyz::dsRed)nz50 (70)
zebrafish were used for all survival experiments. Embryos were obtained
from naturally spawning zebrafish, and maintained at 28.5 °C until 3 dpf in
embryo medium (0.5× E2 medium supplemented with 0.3 g/mL methylene
blue) (71). For injections, larvae were anesthetized with 200 μg/mL tricaine
(Sigma-Aldrich) in embryo medium. Hindbrain ventricle infections were
carried out at 3 dpf and incubated at 33 °C unless specified otherwise.
Bacteria were subcultured following overnight growth until they reached
OD600 of 0.6. For injection of larvae, bacteria were recovered by centrifu-
gation, washed, and resuspended in 1× PBS, 0.1% phenol red, 1% poly-
vinylpyrrolidone to the required cfu/mL. Anesthetized larvae were
microinjected in the hindbrain ventricle with 1 to 2 nL of bacterial suspen-
sion. At the indicated times, larvae were killed in tricaine, lysed with 200 μL
of 0.4% Triton X-100, and homogenized mechanically. Larval homogenates
were serially diluted and plated onto TSB agar. Only larvae having survived
the infection were included for enumeration of cfu. For zebrafish virulence
assays, all S. aureus strains were chromosomally tagged with GFP, which
included RN6390 wild-type, and isogenic Δess, ΔtspA, and ΔesaD strains. For
in vivo competition experiments, COL (attacker) strains were chromosomally
tagged with mCherry and RN6390 (target) strains with GFP. Attacker and
target strains were subcultured, harvested, and resuspended in PBS as
above. Attacker and target strains were mixed at a 1:1 ratio and injected in
the hindbrain ventricle, with 1 to 2 nL of bacterial suspension. Larvae were
killed at 15 hpi or 24 hpi, serially diluted and plated on TSB agar, and at-
tacker and target strains were enumerated by fluorescence (GFP and
mCherry). Quantitative reverse transcription PCR and S. aureus-leukocyte
microscopy methods are described in SI Appendix, SI Materials and Meth-
ods. Animal experiments were performed according to the Animals (Scien-
tific Procedures) Act 1986 and approved by the UK Home Office (Project
licenses: PPL P84A89400 and P4E664E3C).
Data Availability Statement. Raw mass spectrometry data that support the
findings of this study have been deposited to the ProteomeXchange Con-
sortium via the PRIDE (72) partner repository (dataset identifier PXD011358).
All other data supporting the findings of this study are available within the
paper and SI Appendix.
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